EQL Pharma AB (publ) (STO:EQL)

EQL Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	2,436	1,229	1,087	974	994	392
Market Cap Growth	142.51%	13.10%	11.64%	-2.05%	153.33%	12.03%
Enterprise Value	2,577	1,317	1,075	1,010	980	377
Last Close Price	83.80	42.30	37.40	33.50	34.20	13.50
PE Ratio	70.39	54.15	35.15	30.86	95.88	144.94
PS Ratio	7.20	4.65	4.18	2.38	5.55	5.45
PB Ratio	11.71	6.92	7.02	7.88	10.90	4.85
P/TBV Ratio	235.86	42.91	20.82	38.62	-	15.77
P/FCF Ratio	-	-	40.02	23.63	16.67	63.44
P/OCF Ratio	-	-	39.36	23.28	16.55	58.67
EV/Sales Ratio	7.62	4.99	4.14	2.47	5.47	5.24
EV/EBITDA Ratio	42.56	33.94	22.70	24.92	59.15	54.29
EV/EBIT Ratio	48.83	40.38	26.01	26.01	85.05	83.26
EV/FCF Ratio	-176.06	-	39.58	24.52	16.43	61.02
Debt / Equity Ratio	0.76	0.68	0.43	0.62	0.96	0.33
Debt / EBITDA Ratio	2.59	2.98	1.37	1.83	5.26	3.87
Debt / FCF Ratio	-	-	2.45	1.85	1.46	4.35
Asset Turnover	0.85	0.80	0.99	1.86	1.09	0.64
Inventory Turnover	1.52	1.74	2.69	7.47	3.62	1.64
Quick Ratio	0.45	0.53	0.83	0.77	0.56	0.75
Current Ratio	1.23	1.22	1.43	1.25	1.03	1.41
Return on Equity (ROE)	18.23%	13.66%	22.21%	29.37%	12.04%	3.40%
Return on Assets (ROA)	8.24%	6.18%	9.87%	11.00%	4.39%	2.50%
Return on Capital (ROIC)	10.37%	7.85%	12.27%	12.84%	5.03%	2.88%
Return on Capital Employed (ROCE)	21.20%	15.41%	24.53%	27.92%	10.61%	5.60%
Earnings Yield	1.43%	1.85%	2.84%	3.24%	1.04%	0.69%
FCF Yield	-0.60%	-1.01%	2.50%	4.23%	6.00%	1.58%
Buyback Yield / Dilution	1.74%	1.56%	-1.59%	-	3.37%	0.60%
Total Shareholder Return	1.74%	1.56%	-1.59%	-	3.37%	0.60%

Source: S&P Capital IQ. Standard template. Financial Sources.